Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christi E Marshall

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Transfusion|January 10, 2019
Financial impact of alternative approaches to reduce bacterial contamination of platelet transfusionsSeema Kacker, Evan M Bloch, Paul M Ness, et al.
Transfusion|April 3, 2018
Implementation of secondary bacterial culture testing of platelets to mitigate residual risk of septic transfusion reactionsEvan M Bloch, Christi E Marshall, Joan S Boyd, et al.
Transfusion|May 12, 2010
Blood wastage reduction using Lean Sigma methodologyEugenie S Heitmiller, Richard B Hill, Christi E Marshall, et al.
Transfusion|August 29, 2018
The epidemiology of bacterial culture-positive and septic transfusion reactions at a large tertiary academic center: 2009 to 2016Sean M Erony, Christi E Marshall, Eric A Gehrie, et al.
Anesthesia and Analgesia|July 19, 2017
Blood Product Utilization Among Trauma and Nontrauma Massive Transfusion Protocols at an Urban Academic Medical CenterEshan U Patel, Paul M Ness, Christi E Marshall, et al.
Transfusion|August 5, 2020
Secondary bacterial culture of platelets to mitigate transfusion-associated sepsis: A 3-year analysis at a large academic institutionAlexander J Fenwick, Eric A Gehrie, Christi E Marshall, et al.
Transfusion|August 3, 2023
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trialsMoises A Huaman, Jay S Raval, James H Paxton, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
The New England Journal of Medicine|March 30, 2022
Early Outpatient Treatment for Covid-19 with Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
JCI Insight|March 14, 2024
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Transfusion|January 10, 2019
Financial impact of alternative approaches to reduce bacterial contamination of platelet transfusionsSeema Kacker, Evan M Bloch, Paul M Ness, et al.
Transfusion|April 3, 2018
Implementation of secondary bacterial culture testing of platelets to mitigate residual risk of septic transfusion reactionsEvan M Bloch, Christi E Marshall, Joan S Boyd, et al.
Transfusion|May 12, 2010
Blood wastage reduction using Lean Sigma methodologyEugenie S Heitmiller, Richard B Hill, Christi E Marshall, et al.
Transfusion|August 29, 2018
The epidemiology of bacterial culture-positive and septic transfusion reactions at a large tertiary academic center: 2009 to 2016Sean M Erony, Christi E Marshall, Eric A Gehrie, et al.
Anesthesia and Analgesia|July 19, 2017
Blood Product Utilization Among Trauma and Nontrauma Massive Transfusion Protocols at an Urban Academic Medical CenterEshan U Patel, Paul M Ness, Christi E Marshall, et al.
Transfusion|August 5, 2020
Secondary bacterial culture of platelets to mitigate transfusion-associated sepsis: A 3-year analysis at a large academic institutionAlexander J Fenwick, Eric A Gehrie, Christi E Marshall, et al.
Transfusion|August 3, 2023
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trialsMoises A Huaman, Jay S Raval, James H Paxton, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
The New England Journal of Medicine|March 30, 2022
Early Outpatient Treatment for Covid-19 with Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
JCI Insight|March 14, 2024
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Pageof 2